| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 25 |
| 1 | VEDOLIZUMAB | 22 |
| 2 | PANTOPRAZOLE | 21 |
| 3 | PEMBROLIZUMAB | 18 |
| 4 | PREDNISONE | 18 |
| 5 | PREDNISOLONE | 16 |
| 6 | PREDNISOLONE ORAL | 16 |
| 7 | PREDNISOLONE ORAL SOLUTION | 16 |
| 8 | ADALIMUMAB | 15 |
| 9 | METHYLPREDNISOLONE | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASIAN GINSENG | 1 | 0.0024 |
| 1 | PYRIMETHAMINE | 2 | 0.0016 |
| 2 | CEFUROXIME | 13 | 0.0011 |
| 3 | CHOLESTYRAMINE | 13 | 0.0011 |
| 4 | TOFACITINIB CITRATE | 12 | 0.0009 |
| 5 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 6 | DHEA (DEHYDROEPIANDROSTERONE) | 1 | 0.0005 |
| 7 | OCTREOTIDE ACETATE | 13 | 0.0004 |
| 8 | GOLIMUMAB | 5 | 0.0004 |
| 9 | IPILIMUMAB | 13 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 2 | 0.0016 |
| 1 | Somatostatin Analog [EPC] | 9 | 0.0013 |
| 2 | Bile Acid Sequestrant [EPC] | 13 | 0.0011 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 13 | 0.0003 |
| 4 | Integrin Receptor Antagonist [EPC] | 22 | 0.0003 |
| 5 | Interleukin-17A Antagonist [EPC] | 8 | 0.0002 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 20 | 0.0002 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 9 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 13 | 0.0001 |